Literature DB >> 19003243

Immortalized cells as experimental models to study cancer.

Jesse S Boehm1, William C Hahn.   

Abstract

The development of cancer is a multi-step process in which normal cells sustain a series of genetic alterations that together program the malignant phenotype. Much of our knowledge of cancer biology results from the detailed study of specimens and cell lines derived from patient tumors. While these approaches continue to yield critical information regarding the identity, number, and types of alterations found in human tumors, further progress in understanding the molecular basis of malignant transformation depends upon the generation and use of increasingly sophisticated experimental models of cancer. Over the past several years, the recognition that telomeres and telomerase play essential roles in regulating cell lifespan now permits the development of new models of human cancer. Here we review recent progress in the use of immortalized human cells as a foundation for understanding the molecular basis of cancer.

Entities:  

Year:  2004        PMID: 19003243      PMCID: PMC3449965          DOI: 10.1007/s10616-004-5125-1

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  104 in total

1.  Species- and cell type-specific requirements for cellular transformation.

Authors:  Annapoorni Rangarajan; Sue J Hong; Annie Gifford; Robert A Weinberg
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

2.  Reconstruction of functionally normal and malignant human breast tissues in mice.

Authors:  Charlotte Kuperwasser; Tony Chavarria; Min Wu; Greg Magrane; Joe W Gray; Loucinda Carey; Andrea Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

3.  The SV40 small t antigen is essential for the morphological transformation of human fibroblasts.

Authors:  A de Ronde; C J Sol; A van Strien; J ter Schegget; J van der Noordaa
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

4.  Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

Authors:  T C Thompson; J Southgate; G Kitchener; H Land
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

5.  Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes.

Authors:  M Stevenson; D J Volsky
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

6.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

7.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

8.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture.

Authors:  H E Ruley
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

9.  Immortalization of human osteoblasts by transferring human telomerase reverse transcriptase gene.

Authors:  Yin Xiaoxue; Chen Zhongqiang; Guo Zhaoqing; Dang Gengting; Ma Qingjun; Wang Shenwu
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

Review 10.  Cellular proteins that are targetted by DNA tumor viruses for transformation.

Authors:  N Dyson; K Buchkovich; P Whyte; E Harlow
Journal:  Princess Takamatsu Symp       Date:  1989
View more
  5 in total

1.  Telomerase immortalization of principal cells from mouse collecting duct.

Authors:  Stacy L Steele; Yongren Wu; Robert J Kolb; Monika Gooz; Courtney J Haycraft; Kent T Keyser; Lisa Guay-Woodford; Hai Yao; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-06

2.  Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer.

Authors:  Hailey A Clancy; Hong Sun; Lisa Passantino; Thomas Kluz; Alexandra Muñoz; Jiri Zavadil; Max Costa
Journal:  Metallomics       Date:  2012-06-19       Impact factor: 4.526

3.  Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs.

Authors:  Stuart Creton; Marilyn J Aardema; Paul L Carmichael; James S Harvey; Francis L Martin; Robert F Newbold; Michael R O'Donovan; Kamala Pant; Albrecht Poth; Ayako Sakai; Kiyoshi Sasaki; Andrew D Scott; Leonard M Schechtman; Rhine R Shen; Noriho Tanaka; Hemad Yasaei
Journal:  Mutagenesis       Date:  2011-08-17       Impact factor: 3.000

Review 4.  Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer.

Authors:  Margarite D Matossian; Alexandra A Giardina; Maryl K Wright; Steven Elliott; Michelle M Loch; Khoa Nguyen; Arnold H Zea; Frank H Lau; Krzysztof Moroz; Adam I Riker; Steven D Jones; Elizabeth C Martin; Bruce A Bunnell; Lucio Miele; Bridgette M Collins-Burow; Matthew E Burow
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-09-24

5.  Screening of Health-Associated Oral Bacteria for Anticancer Properties in vitro.

Authors:  Divyashri Baraniya; Vinay Jain; Ronald Lucarelli; Vincent Tam; Lisa Vanderveer; Sumant Puri; Maobin Yang; Nezar Noor Al-Hebshi
Journal:  Front Cell Infect Microbiol       Date:  2020-10-06       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.